Clementia

IPO

Public · Montreal, Canada · Founded 2013 · $92.5M raised

Headquarters
Montreal
Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$92.5M
Last Round
$60.0M Venture RoundJun 2015
Rounds
3
Type
Public

About

Clementia Pharmaceuticals was a Montreal-based rare disease biopharmaceutical company founded in 2011. Its lead compound palovarotene, a retinoic acid receptor gamma agonist, was in clinical development for fibrodysplasia ossificans progressiva and multiple osteochondromas. Clementia was acquired by Ipsen in 2019 for approximately $1.3 billion.

Summary

Clementia is a Biotech company based in Montreal, Canada, founded in 2013. It has raised $92.5M in total across 3 rounds, most recently a $60.0M Venture Round round in Jun 2015. Investors include OrbiMed, New Enterprise Associates and UCB.

Tech & App Stack

15 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOAug 2017
$120.0M

Sign up to see all 4 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Clementia on Indexed.vc
<a href="https://indexed.vc/companies/clementia"><img src="https://indexed.vc/api/badge/company/clementia" alt="Clementia on Indexed.vc" width="260" height="76" /></a>